PharmaResources (China) Performance
| 301230 Stock | 27.00 0.62 2.24% |
On a scale of 0 to 100, PharmaResources holds a performance score of 11. The company holds a Beta of -1.56, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning PharmaResources are expected to decrease by larger amounts. On the other hand, during market turmoil, PharmaResources is expected to outperform it. Please check PharmaResources' market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether PharmaResources' historical price patterns will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in PharmaResources Co Ltd are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, PharmaResources sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0156 | Payout Ratio 0.0734 | Last Split Factor 1.3:1 | Forward Dividend Rate 0.43 | Ex Dividend Date 2024-10-24 |
1 | 3 High Growth Stocks With Strong Insider Confidence - Yahoo Finance | 12/06/2024 |
| Dividend Yield | 0.0156 | |
| Payout Ratio | 0.0734 |
PharmaResources |
PharmaResources Relative Risk vs. Return Landscape
If you would invest 1,908 in PharmaResources Co Ltd on September 19, 2024 and sell it today you would earn a total of 792.00 from holding PharmaResources Co Ltd or generate 41.51% return on investment over 90 days. PharmaResources Co Ltd is generating 0.7129% of daily returns and assumes 4.9753% volatility on return distribution over the 90 days horizon. Simply put, 44% of stocks are less volatile than PharmaResources, and 86% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
PharmaResources Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PharmaResources' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PharmaResources Co Ltd, and traders can use it to determine the average amount a PharmaResources' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1433
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 301230 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.98 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.71 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average PharmaResources is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PharmaResources by adding it to a well-diversified portfolio.
PharmaResources Fundamentals Growth
PharmaResources Stock prices reflect investors' perceptions of the future prospects and financial health of PharmaResources, and PharmaResources fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PharmaResources Stock performance.
| Return On Equity | 0.0064 | ||||
| Return On Asset | -0.0102 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 3.68 B | ||||
| Shares Outstanding | 139.59 M | ||||
| Price To Book | 3.69 X | ||||
| Price To Sales | 7.33 X | ||||
| Revenue | 513.91 M | ||||
| EBITDA | 474.26 K | ||||
| Book Value Per Share | 7.59 X | ||||
| Earnings Per Share | (0.05) X | ||||
About PharmaResources Performance
By analyzing PharmaResources' fundamental ratios, stakeholders can gain valuable insights into PharmaResources' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PharmaResources has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PharmaResources has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PharmaResources is entity of China. It is traded as Stock on SHE exchange.Things to note about PharmaResources performance evaluation
Checking the ongoing alerts about PharmaResources for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PharmaResources help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PharmaResources appears to be risky and price may revert if volatility continues | |
| PharmaResources has high likelihood to experience some financial distress in the next 2 years | |
| About 53.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: 3 High Growth Stocks With Strong Insider Confidence - Yahoo Finance |
- Analyzing PharmaResources' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PharmaResources' stock is overvalued or undervalued compared to its peers.
- Examining PharmaResources' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PharmaResources' management team can have a significant impact on its success or failure. Reviewing the track record and experience of PharmaResources' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PharmaResources' stock. These opinions can provide insight into PharmaResources' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PharmaResources Stock analysis
When running PharmaResources' price analysis, check to measure PharmaResources' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaResources is operating at the current time. Most of PharmaResources' value examination focuses on studying past and present price action to predict the probability of PharmaResources' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaResources' price. Additionally, you may evaluate how the addition of PharmaResources to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |